Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexaria Bioscience Corp LEXX

Alternate Symbol(s):  LEXXW

Healthcare
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.


NDAQ:LEXX - Post by User

Lexaria Bioscience Corp
Bullboard Posts
User Avatar Image
(1)
•••
Post by Yowza123on Mar 30, 2019 1:51pm
167 Views
Post# 29558755

Nuka Enterprises (1906 Chocolates)

Nuka Enterprises (1906 Chocolates)For those newbies to Lexaria, monetization of the company will likely be increasing with the expansion of 1906 chocolates into Canada through their link through Lexaria to Cannfections Chocolates. 1906 also has plans to sell to states other than just Colorado:
Under the new ten year semi-exclusive agreement, Nuka Enterprises will leverage DehydraTECH™ in its U.S.-based products with a focus on recreational states like Colorado, Nevada, California, New Jersey, and Massachusetts. The company also has acquired an option to expand its products and brand to Canada, including through the use of Lexaria’s existing chocolate and confections contract manufacturer licensee, Cannfections Group Inc.
Here's a link to the article:
https://www.otcmarkets.com/stock/lxrp/news/Lexaria-Solidifies-Presence-in-Edibles-Market-with-New-Agreement----CFN-Media?id=191328


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities